Vietnamese-American nurse Nina Pham has recovered from Ebola.

Health officials in Texas, USA, announced that Nina Pham, a Vietnamese-American nurse, has recovered from Ebola and will be discharged from the hospital on October 24th.

The medical treatment center in Bethesda, Maryland, where Nina Pham is being treated, announced that it will hold a press conference at 11:30 local time (10:30 PM Vietnam time) to discuss the details of the nurse's case.

US President Barack Obama receives nurse Nina Pham at the White House after she was declared free of Ebola (Source: AP)

Nina Pham was the first case of Ebola virus infection in the United States. She and nurse Amber Vinson contracted the virus while treating patient Thomas Duncan, a Liberian who died on October 8th in the US. Amber Vinson is currently being treated at Emory University Hospital in Atlanta.

On October 24th, the US also confirmed another case of Ebola infection: Dr. Craig Spencer, who returned after treating Ebola patients in Guinea.

Regarding efforts to contain the epidemic, on October 24, Chinese President Xi Jinping announced that China would provide approximately $82 million in aid to West African countries heavily affected by the dangerous virus, including Liberia, Sierra Leone, and Guinea.

President Xi Jinping stated that China would provide cash and material aid, send experts and medical personnel, and assist in building treatment centers in Liberia.

Earlier that day, leaders of European Union (EU) member states agreed to increase aid to West Africa to 1 billion euros (1.26 billion USD) to combat the Ebola epidemic.

Meanwhile, the World Health Organization (WHO) said that trials of an Ebola vaccine could begin in West Africa this December, with hundreds of thousands of doses then being made available for widespread use in the first half of 2015.

Speaking after a meeting between the WHO and officials, health experts, government officials from countries affected by the Ebola outbreak, as well as pharmaceutical companies and donors, WHO Assistant Director-General Marie-Paule Kieny said that the two vaccines to be tested soon are rVSV, developed by the National Microbiology Laboratory of Canada, and ChAd3, manufactured by the British pharmaceutical company GlaxoSmithKline. rVSV has already begun trials in the US and is expected to be tested in Switzerland, Germany, Gabon, and Kenya.

Meanwhile, ChAd3 is being tested in the US, UK, and Mali, and will continue to be tested in Switzerland. WHO staff are being encouraged to test this vaccine. In addition, five other potential vaccines, provided by the UK and Russia, will be tested in the early months of 2015.

The latest figures released by the WHO show that the Ebola epidemic has killed 4,555 people out of 9,216 confirmed cases. Liberia, Sierra Leone, and Guinea are the West African countries most severely affected by the epidemic.

According to VNA